Ajax-Loading

AbbVie Inc - Cash and Equivalents

AbbVie Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Cash-and-Equivalents" stands at 5.63 Billion United States Dollars as of 09/30/2025.

As of the end of AbbVie Inc's third quarter, the item "Cash and Equivalents" stands at 5.63 Billion USD. This represents a decrease of -12.96 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -22.43 percent compared to the value the year prior.
The 1 year change in percent is -22.43.
The 3 year change in percent is -52.43.
The 5 year change in percent is -28.66.
The 10 year change in percent is -38.97.

The Serie's long term average value is 8.66 Billion United States Dollars. It's latest available value, on 09/30/2025, is 35.02 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2010, to it's latest available value, on 09/30/2025, is +58,267.90%.
The Serie's change in percent from it's maximum value, on 03/31/2020, to it's latest available value, on 09/30/2025, is -86.32%.

Cash and Equivalents for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Cash and Equivalents905,699,262,464.00
LogoJohnson & Johnson - Cash and Equivalents486,508,953,600.00
LogoRoche Holding AG - Cash and Equivalents317,433,206,677.55
LogoAstraZeneca PLC - Cash and Equivalents280,205,508,085.11
LogoNovartis AG - Cash and Equivalents255,096,620,580.91